- Home
- ESGL vs VIGL Comparison
ESGL vs VIGL Comparison
Compare ESGL & VIGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ESGL
- VIGL
- Stock Information
- Founded
- ESGL 1999
- VIGL 2020
- Country
- ESGL Singapore
- VIGL United States
- Employees
- ESGL N/A
- VIGL N/A
- Industry
- ESGL
- VIGL Biotechnology: Pharmaceutical Preparations
- Sector
- ESGL
- VIGL Health Care
- Exchange
- ESGL Nasdaq
- VIGL Nasdaq
- Market Cap
- ESGL 114.8M
- VIGL 134.9M
- IPO Year
- ESGL N/A
- VIGL 2022
- Fundamental
- Price
- ESGL $2.96
- VIGL $7.92
- Analyst Decision
- ESGL
- VIGL Buy
- Analyst Count
- ESGL 0
- VIGL 7
- Target Price
- ESGL N/A
- VIGL $8.00
- AVG Volume (30 Days)
- ESGL 61.5K
- VIGL 3.6M
- Earning Date
- ESGL 07-01-2025
- VIGL 08-12-2025
- Dividend Yield
- ESGL N/A
- VIGL N/A
- EPS Growth
- ESGL N/A
- VIGL N/A
- EPS
- ESGL N/A
- VIGL N/A
- Revenue
- ESGL $6,099,784.00
- VIGL N/A
- Revenue This Year
- ESGL N/A
- VIGL N/A
- Revenue Next Year
- ESGL N/A
- VIGL N/A
- P/E Ratio
- ESGL N/A
- VIGL N/A
- Revenue Growth
- ESGL N/A
- VIGL N/A
- 52 Week Low
- ESGL $0.90
- VIGL $1.31
- 52 Week High
- ESGL $3.04
- VIGL $7.95
- Technical
- Relative Strength Index (RSI)
- ESGL 77.20
- VIGL 88.71
- Support Level
- ESGL $2.92
- VIGL $7.86
- Resistance Level
- ESGL $3.04
- VIGL $7.90
- Average True Range (ATR)
- ESGL 0.13
- VIGL 0.03
- MACD
- ESGL 0.03
- VIGL -0.18
- Stochastic Oscillator
- ESGL 88.83
- VIGL 80.00
About ESGL ESGL Holdings Limited
ESGL Holdings Ltd is a waste management, treatment, and recycling company involved in the collection and recycling of hazardous and non-hazardous industrial waste from customers such as pharmaceutical, semiconductor, petrochemical, and electroplating companies.
About VIGL Vigil Neuroscience Inc.
Vigil Neuroscience Inc is a clinical-stage biotechnology company engaged in improving the lives of patients, caregivers, and families affected by rare and common neurodegenerative diseases by pursuing the development of disease-modifying therapeutics to restore the vigilance of microglia. Microglia are the sentinel immune cells of the brain and play a critical role in maintaining central nervous system (CNS) health and responding to damage caused by disease. The group provides solutions for fully human monoclonal antibody and Oral small molecule TERM2 agonist.